Literature DB >> 23971385

[Diagnostic hysteroscopy indications and results in Complexo Hospitalario Universitario De Ourense].

Mónica Pato-Mosquera1, Marta Vázquez-Rodríguez, Marta Pérez-Adán, María Jesús García-García, Susana Blanco-Pérez.   

Abstract

BACKGROUND: Diagnostic hysteroscopy is an endoscopic technique that allows the evaluation of the endocervical canal and uterine cavity.
OBJECTIVE: To evaluate indications, complications and referral to operative hysteroscopy. To analyze the correlation between sonographic display, hysteroscopy findings and histological diagnosis.
MATERIALS AND METHODS: Retrospective and descriptive study of 904 patients who underwent diagnostic hysteroscopy between January 1, 2008 and June 30, 2012.
RESULTS: The most frequent indication was sonographic detection of endometrial polyps (75% were premenopausal and 71.2% postmenopausal). The complication rate associated with the test was 11.4%. The reduction experimented in operative hysteroscopies was from 31.2% in 2008 to 12.2% between January and June 2012. When a polyp or a myoma was detected by sonography, diagnostic hysteroscopy showed them in 64.4% y 62.5% of the cases, respectively. The correlation between hysteroscopic findings and histopathologic diagnosis was 77.7% for normal endometrium, 77.9% for polyps, 17.8% for hyperplasic appearance and 100% for carcinoma suspicion.
CONCLUSIONS: Diagnostic hysteroscopy is a safe technique that allows small interventions avoiding operative hysteroscopies. There is a good relation between hysteroscopic visual inspection and anatomopathologic diagnosis, but biopsy should be taken except if normal endometrium is visualized.

Entities:  

Mesh:

Year:  2013        PMID: 23971385

Source DB:  PubMed          Journal:  Ginecol Obstet Mex        ISSN: 0300-9041


  1 in total

1.  Endometrial study in patients with postmenopausal metrorrhagia.

Authors:  María C Serna Torrijos; Gaspar González de Merlo; Esteban González Mirasol; María Teresa Gómez García; Carmen Ángel Parra; Enrique Iglesias Goy
Journal:  Arch Med Sci       Date:  2016-05-18       Impact factor: 3.318

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.